How Laser Tattoo Removal Works: What Happens Beneath the Skin

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Removing a tattoo using lasers can be considered an “erase” procedure, although this is not entirely accurate. The process is much more gradual, combining lasers and the natural response of the immune system of the body to break up the pigments used in the tattoo. Even though a tattoo seems to appear just above the […]

The post How Laser Tattoo Removal Works: What Happens Beneath the Skin appeared first on Medical News Bulletin.

Bulletin: GLP-1RAs Help Reduce Obesity Related Cancers

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

People who lose weight using GLP-1 receptor antagonists cut their risk of developing obesity-related cancer by as much as 41% compared to folk trying to lose weight with diet and exercise alone. According to the authors of a new study from Houston Methodist Hospital, Houston, Texas, USA, semaglutide (Ozempic) and tirzepatide (Mounjaro) are helping people […]

The post Bulletin: GLP-1RAs Help Reduce Obesity Related Cancers appeared first on Medical News Bulletin.

What Makes Nursing a Rewarding Long-Term Profession

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Nurses step into rooms where people could be worried, a bit uncomfortable, hopeful, and sometimes all three at once. That’s the part everyone sees. But what is it that keeps nurses in this profession for years? The work stays meaningful. One day, you’re helping someone through bad news. Later that day, you’re watching another patient […]

The post What Makes Nursing a Rewarding Long-Term Profession appeared first on Medical News Bulletin.

Bausch + Lomb launches preservative-free Blink Triple Care

A preservative-free version of Blink Triple Care lubricating eye drops for the relief of dry eye symptoms will be available by the end of June, according to a press release from Bausch + Lomb.
“The new Blink Triple Care Preservative Free formulation offers the same proven combination of ingredients while eliminating preservative exposure for patients who use drops frequently or have sensitive ocular surfaces,” Jessilin Quint, OD, MBA, FAAO, a consultant for Bausch + Lomb, told Healio. “This allows clinicians to recommend long-term, consistent dry eye management with greater

AMA calls for AI regulations in clinics, insurance

The AMA adopted new AI policies in a bid to ensure that the technology supports evidence-based medicine, bolsters patient care and serves under a physician’s oversight, instead of replacing their discernment.
According to an AMA press release, AI technologies could help with efficiency and synthesizing information, but there are still important concerns for bias, long-term impact on both physicians and patient outcomes, explainability and transparency.
These new policies, which address AI’s growing popularity in both the clinical and health insurance decision-making realms, emphasize that AI

Johnson & Johnson expands US availability of Tecnis PureSee IOL

Editor’s note: This is a developing news story. Please check back soon for updates.
Johnson & Johnson is expanding availability of the presbyopia-correcting Tecnis PureSee IOL in the United States, according to a press release.
“With the full U.S. availability of Tecnis PureSee IOL, we are expanding access to an important extended depth of focus option that reflects our commitment to innovation, visual quality and patient satisfaction,” Erin Powers, president, surgical vision, North America, Johnson & Johnson, said in the release. “Patients today want vision solutions that support how

Experts: Measles is top infectious threat this summer, not Ebola or hantavirus

Infectious disease experts say measles — not Ebola or hantavirus — is the biggest infectious threat to the mega-events that will be held in the Unites States this summer.
Ahead of the World Cup and America's 250th anniversary celebrations, experts warned that the highly contagious measles virus could spread during massive international gatherings in jam-packed stadiums, crowded transit hubs and fan fests.
“Ebola virus and hantavirus, those are the least of our worries,” Jeanne M. Marrazzo, MD, MPH, FIDSA, CEO of the Infectious Diseases Society of America, said during a Zoom call with reporters

Multiple sclerosis disease activity test may help guide therapies

An MS disease activity score test was found to be effective in monitoring underlying disease activity specific to disease-modifying therapies, according to an exploratory analysis.
This finding, presented as a poster at the Consortium of Multiple Sclerosis Centers Annual Meeting, suggests the Octave Multiple Sclerosis Disease Activity (MSDA) Test could help clinicians more effectively adapt therapies for patients and assess real-time disease activity.
“The MSDA Test was developed to address a longstanding challenge in multiple sclerosis care: the need for a more objective and accessible way to

Who bears responsibility for errors related to ambient AI?

Click here to read the Cover Story, “AI scribes may have ‘profound impact’ on patient care.’”
Imagine a scenario: A physician discusses a potential treatment with a patient in the office but does not recommend it.
The physician’s ambient listening technology hallucinates a recommendation for that treatment and documents this in the electronic health record. The patient reads the note, undergoes the treatment and suffers a serious adverse reaction. The patient sues. Who is responsible?
Ambient listening tools have exploded in health care. In a recent report by Healio, the authors estimate that

ACG cautions new CRC screening guideline may mislead patients

ACG has issued a statement urging clinicians to interpret American Cancer Society’s revised colorectal cancer screening guidance with caution.
In the statement, ACG expressed concern that the recommendation of blood-based tests for some patients risks undermining adherence to higher-sensitivity screening options.
The new American Cancer Society (ACS) guidance reaffirms that adults at average risk for CRC should be screened between ages 45 and 75 years, but recommends blood-based tests as a “not preferred” option for patients who decline or do not complete stool-based screening or colonoscopy.